September 25, 2026, Noon - 1:00 p.m. Grand Rounds – LAMP Capstone Projects Chandler Hospital room HG611
Event Details
After this session, participants will be able to:
- Describe strategies to improve access to care for patients with glomerular diseases within the University of Kentucky referral network.
- Review future directions and scalable lessons from the Hepatitis B screening/vaccination initiative
- Identify differences in plasma lipoprotein profiles between sepsis survivors and non-survivors
- Describe the clinical impact and management considerations of Alpha-1 Antitrypsin Deficiency (AATD)
Describe the relationship between pancreatitis, metabolic bone disease, and fracture risk
Featured Speakers
Rachel L. Hill, Ph.D.: Metabolic Bone Disease and Fracture Risk in Pancreatitis in KY
Malik Khurram Khan, M.D.: Improve care for our Alpha 1 antitrypsin Deficiency (AATD) patients by building a new AATD multidisciplinary clinic at University of Kentucky, recognized as a ‘Clinical Resource center’ (CRC) with the Alpha-1 foundation
Armaghan-e-Rehman Mansoor, M.B.B.S: Hepatitis B Screening at Bluegrass Care Clinic
Mark Rudy, M.D.: UK Glomerular Diseases Center of Excellence
Preetha Shridas, Ph.D.: Plasma Cholesterol and Lipoprotein Profiles in Sepsis: Associations with Mortality and Clinical Outcomes in the ARDSNetSAILS Trial